BCTXW

BriaCell Therapeutics Corp. BCTXW

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode BCTXW BCTX GOVXW IMTXW ATNFW RVPHW
6M -22.61 % -73.93 % -89.43 % -98.78 % 4 958.82 % -7.34 %
YTD -79.12 % -86.87 % -97.81 % -99.80 % 3 809.09 % -80.37 %
1Y -82.35 % -91.50 % -97.67 % -99.98 % 6 515.38 % -44.79 %
3Y -98.04 % -98.85 % -98.05 % -99.98 % 343.30 % -91.12 %
5Y -92.01 % 118 490.46 % -99.52 % -99.98 % 58.61 % -88.22 %
10Y -92.01 % 65 538 259 526 809 974 001 073 641 226 240.00 % -99.59 % -99.99 % 115.00 % -85.28 %
From the beginning -92.01 % 1 748 851 454 723.89 % -99.59 % -99.99 % 115.00 % -85.28 %

Dividend